Steven Cohen's ANRO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 502,950 shares of Alto Neuroscience, Inc. (ANRO) worth $13.27 M, representing 0.01% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ANRO, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 714,461 shares. Largest reduction occurred in Q1 2026, reducing 1.1 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Alto Neuroscience (ANRO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Alto Neuroscience (ANRO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -137 | Reduce 0.03% | 502,950 | $26.39 |
| Q1 2026 | -1.1 M | Reduce 68.69% | 503,087 | $22.48 |
| Q4 2025 | +274,517 | Add 20.60% | 1.61 M | $17.80 |
| Q3 2025 | +2,682 | Add 0.20% | 1.33 M | $4.02 |
| Q2 2025 | +89,702 | Add 7.23% | 1.33 M | $2.20 |
| Q1 2025 | -452,100 | Reduce 26.72% | 1.24 M | $2.16 |
| Q4 2024 | +714,461 | Add 73.08% | 1.69 M | $4.23 |
| Q3 2024 | -72,345 | Reduce 6.89% | 977,692 | $11.44 |
| Q2 2024 | -74,963 | Reduce 6.66% | 1.05 M | $10.69 |
| Q1 2024 | +1.12 M | New Buy | 1.12 M | $15.35 |
Steven Cohen's Alto Neuroscience Investment FAQs
Steven Cohen first purchased Alto Neuroscience, Inc. (ANRO) in Q1 2024, acquiring 1,125,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Alto Neuroscience, Inc. (ANRO) for 10 quarters since Q1 2024.
Steven Cohen's largest addition to Alto Neuroscience, Inc. (ANRO) was in Q1 2024, adding 1,125,000 shares worth $17.27 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 502,950 shares of Alto Neuroscience, Inc. (ANRO), valued at approximately $13.27 M.
As of the Q2 2026 filing, Alto Neuroscience, Inc. (ANRO) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Alto Neuroscience, Inc. (ANRO) was 1,692,153 shares, as reported at the end of Q4 2024.